SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Unilever PLC (UNLYF) trades at a trailing P/E of 21.1, forward P/E of 18.1. Trailing earnings yield is 4.73%, forward earnings yield 5.51%. PEG 1.12.
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (21.1); earnings yield beats bond yields (4.73%).
- Forward P/E 18.1 (down from trailing 21.1) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.12 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 4.73% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.51% as earnings recover.
Overall SharesGrow Score: 55/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — UNLYF
Valuation Multiples
P/E (TTM)21.1
Forward P/E18.1
PEG Ratio1.12
Forward PEG1.10
P/B Ratio0.00
P/S Ratio2.50
EV/EBITDA0.0
Per Share Data
EPS (TTM)$2.72
Forward EPS (Est.)$3.17
Book Value / Share$0.00
Revenue / Share$23.01
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.73%
Forward Earnings Yield5.51%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.82 |
$52.71B |
$5.18B |
9.8% |
| 2017 |
$2.15 |
$53.72B |
$6.05B |
11.3% |
| 2018 |
$3.48 |
$50.98B |
$9.39B |
18.4% |
| 2019 |
$2.14 |
$51.98B |
$5.63B |
10.8% |
| 2020 |
$2.12 |
$50.72B |
$5.58B |
11% |
| 2021 |
$2.32 |
$52.44B |
$6.05B |
11.5% |
| 2022 |
$2.92 |
$60.07B |
$7.64B |
12.7% |
| 2023 |
$2.56 |
$59.6B |
$6.49B |
10.9% |
| 2024 |
$2.29 |
$60.76B |
$5.74B |
9.5% |
| 2025 |
$2.72 |
$50.5B |
$5.99B |
11.9% |
